With not enough orders for Covishield from the Centre, Serum Institute of India CEO Adar Poonawalla on Tuesday said the company is looking at slashing monthly production of vaccines by at least 50% %. SII has written to the government to seek clarity on its requirement, if any, for normal two doses for eligible people and also on booster doses.
from Times of India https://ift.tt/3drJEMD
No comments:
Post a Comment